These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37583808)
21. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048 [TBL] [Abstract][Full Text] [Related]
23. Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner. Habrich J; Boeke S; Fritz V; Koerner E; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D Radiother Oncol; 2024 Feb; 191():110046. PubMed ID: 38070687 [TBL] [Abstract][Full Text] [Related]
24. Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator. Fernando N; Tadic T; Li W; Patel T; Padayachee J; Santiago AT; Dang J; Chung P; Gutierrez E; Coolens C; Taylor E; Winter JD Phys Imaging Radiat Oncol; 2024 Apr; 30():100570. PubMed ID: 38544680 [TBL] [Abstract][Full Text] [Related]
25. Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study. Subesinghe M; Scarsbrook AF; Sourbron S; Wilson DJ; McDermott G; Speight R; Roberts N; Carey B; Forrester R; Gopal SV; Sykes JR; Prestwich RJ BMC Cancer; 2015 Mar; 15():137. PubMed ID: 25885109 [TBL] [Abstract][Full Text] [Related]
26. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer. Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730 [TBL] [Abstract][Full Text] [Related]
27. Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis. Hafeez S; Koh M; Jones K; El Ghzal A; D'Arcy J; Kumar P; Khoo V; Lalondrelle S; McDonald F; Thompson A; Scurr E; Sohaib A; Huddart R Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):630-641. PubMed ID: 35534398 [TBL] [Abstract][Full Text] [Related]
28. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation. Liu Y; Zhang Y; Cheng R; Liu S; Qu F; Yin X; Wang Q; Xiao B; Ye Z J Magn Reson Imaging; 2019 Jan; 49(1):280-290. PubMed ID: 29761595 [TBL] [Abstract][Full Text] [Related]
29. Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator. Wong OL; Yuan J; Poon DMC; Chiu ST; Yang B; Chiu G; Yu SK; Cheung KY Magn Reson Imaging; 2024 Sep; 111():47-56. PubMed ID: 38513789 [TBL] [Abstract][Full Text] [Related]
30. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897 [TBL] [Abstract][Full Text] [Related]
31. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation. Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349 [TBL] [Abstract][Full Text] [Related]
32. Detectability of radiation-induced changes in magnetic resonance biomarkers following stereotactic radiosurgery: A pilot study. Winter JD; Moraes FY; Chung C; Coolens C PLoS One; 2018; 13(11):e0207933. PubMed ID: 30475887 [TBL] [Abstract][Full Text] [Related]
33. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy. Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898 [TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents. Barendregt AM; van Gulik EC; Lavini C; Nusman CM; van den Berg JM; Schonenberg-Meinema D; Dolman KM; Kuijpers TW; Hemke R; Maas M Eur Radiol; 2017 Nov; 27(11):4889-4899. PubMed ID: 28608162 [TBL] [Abstract][Full Text] [Related]
35. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer. Makino H; Kato H; Furui T; Morishige K; Kanematsu M J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754 [TBL] [Abstract][Full Text] [Related]
36. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. Ding Y; Hazle JD; Mohamed AS; Frank SJ; Hobbs BP; Colen RR; Gunn GB; Wang J; Kalpathy-Cramer J; Garden AS; Lai SY; Rosenthal DI; Fuller CD NMR Biomed; 2015 Dec; 28(12):1645-54. PubMed ID: 26451969 [TBL] [Abstract][Full Text] [Related]
37. Quantitative comparison of MR diffusion-weighted imaging for liver focal lesions between 3.0T and 1.5T: Regions of interest of the minimum-spot ADC, the largest possible solid part, and the maximum diameter in lesions. Tang Y; Wang H; Wang Y; Li J; Jia R; Ma L; Ye H J Magn Reson Imaging; 2016 Nov; 44(5):1320-1329. PubMed ID: 27080350 [TBL] [Abstract][Full Text] [Related]
38. Multimodal magnetic resonance imaging in the diagnosis of cervical cancer and its correlation with the differentiation process of cervical cancer. Meng H; Guo X; Zhang D BMC Med Imaging; 2023 Sep; 23(1):144. PubMed ID: 37773061 [TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers. McDonald BA; Salzillo T; Mulder S; Ahmed S; Dresner A; Preston K; He R; Christodouleas J; Mohamed ASR; Philippens M; van Houdt P; Thorwarth D; Wang J; Shukla Dave A; Boss M; Fuller CD Radiother Oncol; 2023 Aug; 185():109717. PubMed ID: 37211282 [TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]